Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M97.9Revenue $M0.1Net Margin (%)--Altman Z-Score4.4
Enterprise Value $M68.5EPS $-0.1Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.0Pre-tax Margin (%)--Higher ROA y-yY
Price/Book4.210-y EBITDA Growth Rate %-2.4Quick Ratio11.1Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %-2.4Current Ratio11.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-22.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-29.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M180ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with RNN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RNNKen Fisher 2014-09-30 Sold Out $0.662 - $0.875
($0.75)
$ 0.55-27%Sold Out0
RNNKen Fisher 2014-06-30 Buy $0.79 - $1.28
($0.95)
$ 0.55-42%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RNN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


RNN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Jeong Tae HeumCFO 2015-01-12Sell317,272$0.91-37.36 view
Ahn Chang HoDirector 2015-01-12Sell314,656$0.91-37.36 view
Ahn Chang HoDirector 2014-06-12Sell136,193$0.99-42.42 view
Jeong Tae HeumCFO 2013-09-09Sell71,139$0.4623.91 view
Kivel RichardDirector 2011-10-03Buy2,500$1.04-45.19 view
Brandt Peter C.Director 2011-09-09Buy125,000$1.17-51.28 view
Brandt Peter C.Director 2011-09-07Buy25,000$0.96-40.63 view
Ahn Chang HoChairman & CEO, 10% Owner 2011-05-18Buy1,008,078$1.31-56.49 view
Ahn Chang HoChairman & CEO, 10% Owner 2011-04-01Buy320,846$1.22-53.28 view
McIntosh David MDirector 2009-07-30Buy5,600$0.8-28.75 view

Quarterly/Annual Reports about RNN:

News about RNN:

Articles On GuruFocus.com
Weekly CEO Buys Highlight: RNN, IIG, FSC, GEO, DAN May 21 2011 
Weekly CEO Buys Highlight: GBDC, EXL, RNN, KYN, CMTL Apr 09 2011 

More From Other Websites
REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 17 2015
Rexahn Pharmaceuticals Awarded Patent in Japan for Novel Targeted Cancer Drug Delivery Platform Jul 14 2015
Rexahn Pharmaceuticals Awarded Patent in Japan for Novel Targeted Cancer Drug Delivery Platform Jul 14 2015
Print Jun 22 2015
Rexahn Announces the Appointment of Peter Brandt as Chairman of the Board Jun 22 2015
Data on Rexahn's RX-3117 in Non-Small Cell Lung Cancer Presented at 16th International Symposium of... Jun 09 2015
Data on Rexahn’s RX-3117 in Non-Small Cell Lung Cancer Presented at 16th International Symposium... Jun 09 2015
National Cancer Institute Accepts Rexahn's RX-21101 for Its Nanotechnology Characterization... Jun 08 2015
National Cancer Institute Accepts Rexahn's RX-21101 for Its Nanotechnology Characterization... Jun 08 2015
REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 05 2015
5 Stocks Under $10 Ready to Spike Higher May 29 2015
Strong Data on Rexahn's Non-Toxic Targeted Therapy Revealed at Top Cancer Meetings May 28 2015
REXAHN PHARMACEUTICALS, INC. Financials May 15 2015
Rexahn Announces Poster Presentations at the 2015 American Society of Clinical Oncology (ASCO)... May 13 2015
Rexahn Announces Poster Presentations at the 2015 American Society of Clinical Oncology (ASCO)... May 13 2015
Rexahn Pharmaceuticals Reports First Quarter 2015 Financial Results and Pipeline Update May 11 2015
Rexahn Pharmaceuticals Reports First Quarter 2015 Financial Results and Pipeline Update May 11 2015
10-Q for Rexahn Pharmaceuticals, Inc. May 10 2015
REXAHN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 08 2015
10-K for Rexahn Pharmaceuticals, Inc. May 04 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK